Based on our data, following histopathology review, tumors classified along the ALGG spectrum including WHO Grades II and III astrocytomas, oligodendrogliomas and mixed tumors could be initially divided based on IDH1/2 mutations into mutant and wildtype groups. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).